In current Levaquin lawsuit news, it has become apparent that fluoroquinolones, like Levaquin (levofloxacin), is the cause of more than just tendon damage, as previously understood. In a recent New York Times article, fluoroquinolone antibiotics have recently been linked to other serious problems affecting ocular and renal health.
The article goes on to cite the fact that this class of antibiotics has been over-prescribed by doctors. According to one pharmacological epidemiologist, prescribing a drug like Levaquin to treat certain infections is sometimes overkill. It appears that the harm caused by Levaquin and other fluoroquinolone antibiotics could be lessened by exploring other treatment options.
Individuals who have taken Levaquin, and have experienced health complications following use, have most often reported incidences of tendon damage, tendon rupture, and tendonitis. Though, in addition to tendon problems, recent research published in The Journal of the American Medical Association reveals that the use of fluoroquinolones like Levaquin has also played a key role in increasing the risk of retinal detachment and kidney failure.
In 2008, the U.S. Food and Drug Administration ordered manufacturers of fluoroquinolones to include a boxed warning about the risk of developing tendonitis and tendon damage while using these kinds of antibiotics. Following the studies showing a connection between Levaquin and damage to retinal and renal health, the FDA recently updated this order to cover information about the link between fluoroquinolone use and neuromuscular problems.
The manufacturer of Levaquin, Janssen Pharms, faces over 2,000 Levaquin lawsuits.
Carey Danis & Lowe Levaquin lawyers are currently investigating Levaquin cases. If you or someone you love has been injured through the use of Levaquin, contact Carey Danis & Lowe today for a free legal evaluation and for assistance in filing a Levaquin lawsuit.
Contact Carey Danis & Lowe by calling 800.721.2519 or by submitting a personal injury claim form.References: Levaquin, Pharmaceutical litigation